Major Bleeding1,*
Event rate (%/year)
0.6
0.5
0.4
0.3
0.2
0.1
0.0
Apixaban 2.5 mg
N = 840
N = 840
Apixaban 5 mg
N = 811
P = NS
N = 811
P = NS
Placebo
N = 826
N = 826
Components of Major Bleeding2
Bleeding outcome |
Apixaban 2.5 mg |
Apixaban 5 mg |
Placebo |
---|---|---|---|
Number of events | |||
Fatal bleeding | 0 | 0 | 0 |
Major intraocular bleeding | 2 | 0 | 1 |
Major GI bleeding | 0 | 1 | 1 |
Intracranial bleeding | 0 | 0 | 1 |
Major urogenital bleeding | 0 | 0 | 1 |